Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Incyte
Pharma
Europe's CHMP reverses endorsement of Amgen's Tavneos
The CHMP has now determined that the Advocate study was “conducted in breach of good clinical practice (GCP) principles,” the EU agency said.
Fraiser Kansteiner
Jun 26, 2026 11:07am
CMS, Incyte settle lawsuit on classification of Opzelura
Jun 23, 2026 1:32pm
ASCO: Incyte positions Monjuvi combo for first-line DLBCL
May 30, 2026 8:00am
PharmaEssentia taps Incyte alum as it eyes Besremi expansion
May 28, 2026 8:08am
FDA lambasts Incyte over ‘misleading’ Niktimvo claims
Apr 27, 2026 9:14am
Novo's Indiana plant claims another victim in Incyte's PD-1
Mar 9, 2026 10:45am
